enGene Names Amy Pott as Chief Global Commercialization Officer
BOSTON & MONTREAL–(BUSINESS WIRE)–enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines... Read more.
David Droga to Step Down as Accenture Song CEO, Appointed Accenture Vice Chair
Accenture Song Americas Lead Ndidi Oteh to Succeed Droga as CEO in new fiscal year starting Sept. 1, 2025 NEW YORK–(BUSINESS WIRE)–Accenture (NYSE: ACN)... Read more.
Acrisure Acquires Payroll Business from Global Payments for $1.1 Billion to Expand its Fintech Product Offering
Addition of new payroll, HR and billing technology further enhances Acrisure’s position as a global fintech leader GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Acrisure... Read more.
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
The company expands precision oncology portfolio with new Paletrra spatial proteomics platform FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics, Inc. (“NeoGenomics”... Read more.
Phreesia Announces First Quarter Fiscal 2026 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.–(BUSINESS WIRE)–Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the “Company”) announced financial results... Read more.
WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program
WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary... Read more.
Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Goldman Sachs 46th Annual Global... Read more.
Everstream Reaches Agreement for Sale of Business to Bluebird Fiber
Provides Strengthened Financial Position to Advance Strategy of Core Market Optimization Customers to Continue Receiving Same Speed, Reliability, and Expert Support... Read more.
Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
Opdivo is the first and only PD-1 inhibitor approved for subcutaneous (SC) use in the European Union Approval is based on results from the Phase 3 CheckMate -67T... Read more.
SunCoke Energy, Inc. Enters Into Definitive Agreement to Acquire Phoenix Global
SunCoke Energy, Inc. to acquire Phoenix Global for $325 million; implies an acquisition multiple of 5.4x 3/31/25 LTM Adjusted EBITDA(1) of $61 million Combined business... Read more.